Lantheus Holdings (LNTH) Change in Account Payables (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Change in Account Payables came in at $190000.0 in Q1 2026, down 96.19% year-on-year from $5.0 million in Q1 2025, and up 100.59% on a QoQ basis from -$32.0 million in Q4 2025.
Lantheus Holdings (LNTH) Change in Account Payables (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Change in Account Payables data on file, last reported at $190000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 96.19% year-over-year to $190000.0 in Q1 2026; TTM through Mar 2026 was -$7.3 million, a 1923.33% decrease from a year earlier, with the FY2025 full-year figure at -$2.5 million, up 71.69% from the prior year.
- Change in Account Payables for Q1 2026 stood at $190000.0, up from -$32.0 million in the prior quarter.
- Over the last five years, Change in Account Payables for LNTH reached as high as $20.1 million in Q3 2025 and fell as low as -$32.0 million in Q4 2025.
- Historically, Change in Account Payables has averaged $375529.4 across 5 years, with a median of $1.5 million in 2022.
- On a YoY basis, Change in Account Payables climbed as much as 933.63% in 2022 and fell as far as 1349.31% in 2022.
- Year by year, Change in Account Payables stood at -$8.1 million in 2022, then jumped by 162.15% to $5.0 million in 2023, then sank by 297.56% to -$10.0 million in 2024, then plunged by 221.09% to -$32.0 million in 2025, then surged by 100.59% to $190000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $190000.0 in Q1 2026, -$32.0 million in Q4 2025, and $20.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,000.00 |
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | -31.97 Mn |
| Dec 31, 2025 | -31.97 Mn |
| Sep 30, 2025 | 20.11 Mn |
| Sep 30, 2025 | 20.11 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | 4.98 Mn |
| Mar 31, 2025 | 4.98 Mn |
| Dec 31, 2024 | -9.96 Mn |
| Dec 31, 2024 | -9.96 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Jun 30, 2024 | 10.34 Mn |
| Jun 30, 2024 | 10.34 Mn |
| Mar 31, 2024 | -3.46 Mn |
| Mar 31, 2024 | -3.46 Mn |
| Dec 31, 2023 | 5.04 Mn |
| Dec 31, 2023 | 5.04 Mn |